first_imgThe European Commission said on Wednesday it had sealed a deal with Pfizer and BioNTech for the supply of up to 300 million doses of their Covid-19 vaccine candidate.The move follows Pfizer’s announcement on Monday that its experimental vaccine developed with BioNTech was more than 90% effective, making them the first drugmakers to show successful interim data from a large-scale clinical trial of a coronavirus vaccine.Under the EU deal, the 27 EU countries could buy 200 million doses, and have an option to purchase another 100 million.- Advertisement – – Advertisement – Under the Pfizer-BioNtech deal, the 27 EU countries could buy 200 million doses, and have an option to purchase another 100 million.NurPhoto | Getty Images The EU has already signed supply deals with AstraZeneca, Sanofi and Johnson & Johnson for their experimental Covid-19 shots, and is talking with Moderna, CureVac and Novavax to secure their vaccines. – Advertisement –last_img

Leave a Reply

Your email address will not be published. Required fields are marked *

*
*